Gero Brockhoff
- Oncology top 2%
- HER2/EGFR in Cancer Research 29
- Cancer Immunotherapy and Biomarkers 12
- Cancer Cells and Metastasis 12
- CAR-T cell therapy research 9
- Cancer Research top 5%
- Cancer Genomics and Diagnostics 8
- Genetics top 5%
- Immunology top 5%
- Immunotherapy and Immune Responses 9
- Immunology and Allergy top 5%
-
- Monoclonal and Polyclonal Antibodies Research 21
-
- Advanced Biosensing Techniques and Applications 9
- Co-authors
- Ferdinand HofstaedterOlaf OrtmannSimone Diermeier‐DaucherRuth KnuechelLeoni A. Kunz‐SchughartMarina KreutzAnja K. WegeStephan Schwarz
- Cited by
- OncologyCancer ResearchGenetics
- Journals
- Oncotarget (7 papers)Cytometry Part A (6 papers)International Journal of Molecular Sciences (5 papers)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Gero Brockhoff
110 papers receiving 3.4k citations
Peers
Comparison fields: 5 of 132
- Oncology 1.5k
- Cancer Research 491
- Genetics 332
- Immunology 518
- Immunology and Allergy 148
Countries citing papers authored by Gero Brockhoff
This map shows the geographic impact of Gero Brockhoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gero Brockhoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gero Brockhoff more than expected).
Fields of papers citing papers by Gero Brockhoff
This network shows the impact of papers produced by Gero Brockhoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gero Brockhoff. The network helps show where Gero Brockhoff may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Gero Brockhoff, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2022 | 8 | |
| 3 | 2022 | 4 | |
| 4 | 2017 | 15 | |
| 5 | 2017 | 26 | |
| 6 | 2017 | 8 | |
| 7 | 2016 | 5 | |
| 8 | 2012 | 45 | |
| 9 | 2011 | 45 | |
| 10 | 2011 | 33 | |
| 11 | EGFR (HER) family protein expression and cytogenetics in 219 squamous cell carcinomas of the upper respiratory tract: ERBB2 overexpression independent prediction of poor prognosis. | 2010 | 15 |
| 12 | 2006 | 111 | |
| 13 | 2006 | 23 | |
| 14 | 2005 | 50 | |
| 15 | 2005 | 143 | |
| 16 | 2004 | 22 | |
| 17 | [The "classical" macrophage marker CD68 is strongly expressed in primary human fibroblasts]. | 2003 | 28 |
| 18 | 2002 | 128 | |
| 19 | 2001 | 46 | |
| 20 | 1994 | 40 |
About Gero Brockhoff
Gero Brockhoff is a scholar working on Oncology, Genetics, Cancer Research, Radiology, Nuclear Medicine and Imaging and Immunology and Allergy, having authored 113 papers that have together received 3.5k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (29 papers), Monoclonal and Polyclonal Antibodies Research (21 papers), Cancer Immunotherapy and Biomarkers (12 papers), Cancer Cells and Metastasis (12 papers), Immunotherapy and Immune Responses (9 papers), CAR-T cell therapy research (9 papers), Advanced Biosensing Techniques and Applications (9 papers) and Cancer Genomics and Diagnostics (8 papers). The work is most often cited by research in Oncology (1.5k citations), Cancer Research (491 citations), Genetics (332 citations), Immunology (518 citations) and Immunology and Allergy (148 citations). Gero Brockhoff has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Ferdinand Hofstaedter, Olaf Ortmann, Simone Diermeier‐Daucher, Ruth Knuechel, Leoni A. Kunz‐Schughart, Marina Kreutz, Anja K. Wege, Stephan Schwarz, Anne Heller and Achim Goepferich. Their work appears in journals such as Oncotarget, Cytometry Part A, International Journal of Molecular Sciences, Cell Proliferation and Cytometry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.